CFHI(SH:601106)2023-04-27 16:00Financial Performance - In 2022, the company's consolidated net profit attributable to shareholders was CNY 103.25 million, a decrease of 38.68% compared to 2021[4]. - The total operating revenue for 2022 was CNY 23.89 billion, reflecting a growth of 3.28% from CNY 23.13 billion in 2021[16]. - The net profit for 2022 was 1.03 billion RMB, a decrease of 22.57% compared to the previous year[31]. - The net profit after deducting non-recurring gains and losses was CNY 11.49 million, a significant drop of 91.55% from CNY 135.97 million in 2021[16]. - The basic earnings per share for 2022 were CNY 0.0151, down 38.62% from CNY 0.0246 in 2021[19]. - The company reported a total comprehensive income of CNY 423,302,800.62 for 2022, compared to a loss of CNY 233,356,658.29 in 2021[199]. Cash Flow and Assets - The net cash flow from operating activities was negative CNY 1.26 billion, a decline of 285.13% compared to a positive cash flow of CNY 682.17 million in 2021[16]. - The company's total assets at the end of 2022 amounted to CNY 41.26 billion, an increase of 7.75% from CNY 38.29 billion at the end of 2021[18]. - The company's cash and cash equivalents decreased by 61.42% to -CNY 327,947,351.12[44]. - The company's total assets include CNY 30,596,729.73 in overseas assets, accounting for 0.07% of total assets[47]. - The company's cash and cash equivalents decreased to CNY 1.38 billion in 2022 from CNY 1.68 billion in 2021, a decline of 17.9%[187]. Liabilities and Equity - Total liabilities reached CNY 29.39 billion in 2022, an increase from CNY 26.75 billion in 2021, which is a rise of 9.1%[189]. - The company's total equity increased to CNY 11,151,166,445.49 in 2022 from CNY 10,727,039,967.28 in 2021, reflecting a growth of about 3.9%[192]. - The company reported a net loss of CNY 5.22 billion in 2022, slightly improved from a loss of CNY 5.32 billion in 2021[189]. Research and Development - The company's R&D expenses increased by 6.40% to 551.92 million RMB, emphasizing a focus on technological innovation[32]. - Total R&D investment reached CNY 986,665,079.22, accounting for 4.13% of operating revenue[41]. - Research and development expenses for 2022 were CNY 551,918,591.06, compared to CNY 518,716,202.27 in 2021, showing an increase of approximately 6.4%[193]. Market and Product Development - The company aims to enhance its market share and profitability by focusing on innovation-driven development and expanding into new industries during the 14th Five-Year Plan period[64]. - The company is focusing on expanding its international market presence while consolidating its domestic market strategy[35]. - The company aims to enhance sustainable operational capabilities by implementing performance-driven and value-oriented budget indicators, ensuring completion of targets[66]. Governance and Compliance - The company has complied with the governance requirements set by the China Securities Regulatory Commission and the Shanghai Stock Exchange, with no significant discrepancies reported[71]. - The company has established a robust mechanism for decision-making, execution, and supervision among the shareholders, board, and management[71]. - The company has implemented a comprehensive compliance management system to mitigate legal and regulatory risks[69]. Environmental Responsibility - The company invested 62.35 million yuan in environmental protection during the reporting period[114]. - The company reported a chemical oxygen demand (COD) discharge concentration of 25.75 mg/L, significantly below the standard value of 100 mg/L[115]. - The company is committed to achieving zero accidents and minimizing emissions as part of its environmental responsibility strategy[68]. Employee and Talent Management - The total number of employees in the parent company and major subsidiaries is 8,276, with 3,422 in the parent company and 4,854 in subsidiaries[98]. - The company conducted 717 training sessions, training over 33,300 employees for a total of 3,412 hours[101]. - The company emphasizes a salary distribution system that favors marketing, high-tech R&D, and senior management roles[100].